J B CHEMICALS AND PHARMA

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Change in Board of Directors'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015-Open Offer by Tau Investment Holdings Pte. Ltd.-Extension of time for dispatch of Letter of Offer granted by SEBI'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015-Purchase of Pharmaceutical Business Undertaking of Lekar Pharma Limited'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Submission of recommendation of Committee of Independent Directors ( IDC ) under Regulation 26(7) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011, as amended.'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of final Dividend 2019-20 is 17-Sep-2020.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015-Notice of Annual General Meeting '.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015-Notice in respect of transfer of equity shares of the Company to Investor Education and Protection Fund (IEPF).'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 -Prior Public Notice for Equity Shareholders of the Company with regard to convening of AGM through Video Conferencing (VC)/Other Audio Visual Means (OAVM).'.

Pallavi Bharat Mehta has submitted to the Exchange a copy of Disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Demise of Mr Jyotindra B Mody, Chairman & Managing Director of the company on July 21, 2020.

Disclosure of related party transactions under Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the second half of the financial year 2019-20 of the Company.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Purchase of Pharmaceutical Business Undertaking of Lekar Pharma Limited'.

��ICICI Securities Limited has submitted to the Exchange a copy of detailed Public Statement in terms of Regulation 3(1), Regulation 4 read with Regulation 13(4), Regulation 14(3), Regulation 15(2) and Regulation 15(3) of The Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended to the Public Shareholders of JB Chemicals & Pharmaceuticals Ltd (Target Company).

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Public Announcement of open offer for acquisition of Company s Equity Shares '.

ICICI Securities Limited has submitted to the Exchange a copy of Public announcement dated July 02, 2020 for the Open offer of��J.B. Chemicals & Pharmaceuticals Limited( Target Company).

Earnings call -for investors/ analysts on July 6, 2020 at 4:00 pm

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2020.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on Jun 25, 2020.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Dividend Updates

��D B Mody HUF��(Pranabh Dinesh Mody Karta of D B Mody HUF)�� ����has submitted to the Exchange a copy of��Disclosures under Regulation 10(6) of SEBI (Substantial Acquisitionof Shares and Takeovers) Regulations, 2011.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'ANDA approval by US FDA '.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Contribution to PM Cares Fund'.

Shirish Mody has informed the Exchange regarding Disclosure under Regulation 30 & 31 of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 -Supreme Court judgement on orders passed by National Green Tribunal'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'News about Ranitidine formulations in the US '.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the Company has fixed Record Date as March 4, 2020 for the purpose of Interim Dividend

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on February 20, 2020, declared Interim Dividend of 10 per equity share.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'US FDA approval of New Solid Oral dosage forms formulations manufacturing facility at Panoli, Gujarat'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Successful US FDA inspection of Solid Oral dosage forms formulations manufacturing facility at Panoli, Gujarat'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Investor Presentation

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Investor Presentation

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Acquisition of trademarks '.

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2019.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on February 04, 2020.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange a copy of Post Buyback Public Announcement.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 20, 2019, titled "Press Release".

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Regulatory one-time increase in price of Metronidazole formulations'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Filing of Letter of Offer pursuant to provisions of the SEBI (Buy-back of Securities) Regulations, 2018.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Approval for re-classification of certain promoter group members to public'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Related Party Transaction disclosure under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange a copy of Public Announcement - Buyback of Shares.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'copy of Board Resolution pursuant to the provisions of SEBI (Buy-Back of Securities) Regulation, 2018'.